Mars makes confectionery, food, and petcare products and also operates pet health services through networks like Banfield, VCA, BluePearl, and Royal Canin. Its products are marketed under familiar brands such as M&M’s, Snickers, Milky Way, Skittles, Dove, Orbit, Pedigree, Royal Canin, Whiskas, and Cocoavia, sold globally to consumers and pet owners. The company differs from competitors by combining a broad, diversified portfolio with a global, family-owned structure guided by the Mars Principles (Quality, Responsibility, Mutuality, Efficiency, Freedom), which drives its operations and partnerships. Mars aims to help communities prosper and to grow its business while improving social and environmental outcomes, using its scale to support responsible practices across the world.
Work here?Claim your company
Industries
Company Size
10,001+
Company Stage
Debt Financing
Total Funding
$27B
Headquarters
McLean, VA
Founded
1911
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$27B
Above
Industry Average
Funded Over
2 Rounds
Mars has appointed João Belo as global vice president, corporate affairs for its Snacking division, effective January 4, 2027. He will report to Andrew Clarke, global president of Mars Snacking, and join the division's leadership team. Belo will oversee global communications, public affairs and community impact. His task is to strengthen the reputation of Mars and its brands and deepen stakeholder trust after the Kellanova integration. He joins from Danaher Corporation, where he was chief communications officer. Earlier, he held senior communications roles at Takeda Pharmaceuticals and AbbVie, in a career of more than 30 years. Mars, a $65bn family-owned business based on combined Mars and Kellanova 2025 net sales, makes brands such as SNICKERS, M&M'S and PRINGLES.
Mars, Incorporated plans to invest an estimated $1.4 billion in its US manufacturing and operations in 2027, the most it has spent in a single year. The company has invested more than $9 billion in US operations since 2017. Early next year, Mars will spend more than $34 million to open four veterinary hospitals: three BluePearl locations in Ellicott City, Maryland, Austin, and Katy, Texas, and a Banfield hospital in Wilmington, North Carolina. They will create up to 195 jobs. Recent projects include $60 million for two Trü Frü production lines in Salt Lake City, and $49 million to bring TEMPTATIONS Lickable Treats production to Columbus, Ohio. Mars has also put $165 million into its Waco, Texas, plant since 2024. "Ninety-four percent of the Mars products sold in the U.S. are made here," said chief financial officer Claus Aagaard.
Mars is investing $60 million to expand manufacturing capacity for Tru Fru, its brand of fruit-based treats, in Utah. The privately held food and pet care company aims to meet fast-growing demand for the snacks, which are frozen and freeze-dried fruit dipped in chocolate and other coatings. Tru Fru's annual revenue has risen to about $500 million, from around $100 million before Mars closed its acquisition of the brand in early 2023, according to the company. The line is now sold in 20 global markets, most recently Australia.
Mars, Incorporated has been named to Forbes' Most Trusted Companies in America list for the second year running. It rose to number 17 of 300 companies from number 40 in 2026. The list weighs employee sentiment, consumer trust, financial performance, business trajectory, media sentiment, and workforce stability. Anton Vincent, president of Mars Snacking North America and Global Ice Cream, said the company thinks "in generations" and invests in its associates, innovation, and communities. Earlier this year, Glassdoor ranked Mars number 6 on its Best Places to Work list. It also placed first on Glassdoor's inaugural Best Places to Work in Manufacturing list. The family-owned company operates 53 factories, labs, and offices in the US, along with more than 2,000 veterinary clinics and hospitals.
Mars, Incorporated has awarded a $2.07 million grant to Elucid, a social enterprise that runs health programmes in agricultural supply chains. The money comes through the Mars Impact Fund and will support Elucid Santé Côte d'Ivoire, the group's local arm. The three-year programme, called BLOOM, runs from 2026 to 2029. It aims to help up to 12,750 cocoa-farming households access national health insurance by removing upfront costs and administrative barriers. The grant also unlocks about $2 million in matching funds from Gavi, the Vaccine Alliance. That money will upgrade rural health facilities and extend vaccination campaigns, mobile clinics and preventive care to more than 200,000 people, including 150,000 children. Mars says the health of farming communities underpins the resilience of its cocoa supply chain.
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs
Industries
Company Size
10,001+
Company Stage
Debt Financing
Total Funding
$27B
Headquarters
McLean, VA
Founded
1911
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs